Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > Goodman and Armoyan Buying
View:
Post by ShiningArmour on Sep 26, 2023 4:51pm

Goodman and Armoyan Buying

More insider buys.

Armoyan and Jonathan buying more shares in the public market.

This is a good sign for things to come
Comment by EbbFlow88 on Sep 27, 2023 12:22pm
It's nice to finally see Goodman buy more in the open market. It will be interesting to see how Armoyan's partnership will unfold with Knight. He originally mentioned he will be passive but would love to know what he's been thinking about this investment.
Comment by longrun86 on Sep 27, 2023 1:00pm
I think Armoyan is probably thinking the same things we are. There is a lot of capital to deploy in the future There are challenges with operating margins that need to be addressed immediately The generic sector is struggling The business development function is underperforming The business has yet to achieve the required scale it needs The shares are quite cheap and there ...more  
Comment by MrMugsy on Sep 30, 2023 5:56pm
I think there is a commment from Armoyan when he started accumulating. I think he's been given the low-down on how this company develops over time and he gets it. That's the kind of investor you want - one that's willing to wait. Hence - fewer investors with larger positions and long time horizons is exactly what the Doctor ordered! 60 people controlling about 70% of the business ... ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities